BioSpace News Archive

Calliditas Therapeutics AB provided an update on its business activities and financial position as well as the initiatives announced to continue to build its organization amid the evolving COVID-19 pandemic, all while promoting the continuity of the development of its late stage R&D portfolio.

The Italfarmaco Group provided an update on the clinical development program of Givinostat, its proprietary histone deacetylase inhibitor, in Duchenne Muscular Dystrophy.

RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced that it will host a conference call to discuss its first quarter 2020 financial results on Monday, May 11th, 2020 at 7:30 a.m. Pacific Time..

Amedisys, Inc., a leading provider of home health, hospice and personal care, announced that it has, through one of its wholly owned subsidiaries, signed a definitive agreement to acquire Homecare Preferred Choice, Inc., doing business as AseraCare Hospice, a national hospice care provider with an executive office in Plano, Texas and administrative support center in Fort Smith, Arkansas.

Amphastar Pharmaceuticals, Inc., announces that the U.S. Food and Drug Administration has granted approval of its Abbreviated New Drug Application for Epinephrine Injection, USP 30mg/30mL Multiple Dose Vial.

Pluristem Therapeutics Inc., a leading regenerative medicine company developing a platform of novel biological therapeutic products, cordially invites investors, the media, and the public to join a signing ceremony and analyst & investor call on Thursday, April 30, 2020.

Statistically significant improvement in Alzheimer’s disease agitation, as measured by the CMAI total score compared to placebo (p=0.010, primary endpoint)

JCR Pharmaceuticals Co., Ltd. announced that it has completed the previously announced acquisition of ArmaGen, Inc., a privately held US biopharmaceutical company headquartered in San Diego, California.

Avellino announced that it has partnered with the OC Health Care Agency to launch the OC COVID-19 Testing Network.

Aurinia Pharmaceuticals Inc., a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, announced the appointment of Joe Miller as Chief Financial Officer.